Axon Enterprise, Inc. (AXON)
NASDAQ: AXON · Real-Time Price · USD
742.47
-13.02 (-1.72%)
At close: Aug 1, 2025, 4:00 PM
743.00
+0.53 (0.07%)
After-hours: Aug 1, 2025, 6:12 PM EDT
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 331.66 | 377.03 | 175.78 | 146.93 | -60.02 | -1.72 | Upgrade |
Depreciation & Amortization | 60.52 | 48.43 | 19.32 | 23.12 | 18.69 | 12.48 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 2.04 | Upgrade |
Loss (Gain) From Sale of Investments | -287.43 | -283.22 | 41.79 | -98.94 | -17.82 | 3.35 | Upgrade |
Stock-Based Compensation | 447.73 | 382.6 | 131.36 | 106.18 | 303.33 | 133.57 | Upgrade |
Provision & Write-off of Bad Debts | 22.29 | 20.07 | 5.48 | 0.7 | - | 1.3 | Upgrade |
Other Operating Activities | -97.76 | -63.92 | -59.64 | 38.05 | -76.41 | -11.75 | Upgrade |
Change in Accounts Receivable | -262.67 | -245.84 | -178.99 | -78.23 | -205.77 | -107.76 | Upgrade |
Change in Inventory | -14.31 | 0.61 | -77.63 | -95.01 | -18.27 | -52.16 | Upgrade |
Change in Accounts Payable | 148.97 | 54.52 | 65.33 | 80.98 | 45.3 | 8.89 | Upgrade |
Change in Unearned Revenue | 170.03 | 155.64 | 146.82 | 155.57 | 175.62 | 65.14 | Upgrade |
Change in Other Net Operating Assets | -68.99 | -37.61 | -80.35 | -43.98 | -40.16 | -14.89 | Upgrade |
Operating Cash Flow | 450.04 | 408.31 | 189.26 | 235.36 | 124.49 | 38.48 | Upgrade |
Operating Cash Flow Growth | 95.97% | 115.74% | -19.59% | 89.05% | 223.52% | -41.40% | Upgrade |
Capital Expenditures | -87.45 | -78.79 | -59.64 | -55.8 | -49.89 | -72.63 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 0.04 | 0.1 | Upgrade |
Cash Acquisitions | -384.05 | -621.82 | -21.09 | -2.1 | -22.39 | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | - | -0.39 | -0.24 | Upgrade |
Investment in Securities | -547.27 | 209.98 | 93.74 | -773.04 | 325.18 | -283.75 | Upgrade |
Other Investing Activities | 0.02 | 0.05 | -0.54 | -0.02 | - | - | Upgrade |
Investing Cash Flow | -1,019 | -490.57 | 12.48 | -830.97 | 252.56 | -356.53 | Upgrade |
Long-Term Debt Issued | - | - | - | 673.77 | - | - | Upgrade |
Long-Term Debt Repaid | - | - | - | -194.99 | - | - | Upgrade |
Net Debt Issued (Repaid) | 1,343 | - | - | 478.78 | - | - | Upgrade |
Issuance of Common Stock | 14.58 | 14.58 | 149.21 | - | 157.13 | 0.3 | Upgrade |
Repurchase of Common Stock | -60.5 | -58.18 | -107.89 | -4.87 | -331.31 | -7.81 | Upgrade |
Other Financing Activities | -26.12 | -1.84 | - | 124.2 | - | 306.78 | Upgrade |
Financing Cash Flow | 1,270 | -45.44 | 41.31 | 598.1 | -174.18 | 299.27 | Upgrade |
Foreign Exchange Rate Adjustments | -3.04 | -6.21 | 2.07 | -3.38 | -1.98 | 1.98 | Upgrade |
Net Cash Flow | 698.76 | -133.91 | 245.12 | -0.89 | 200.89 | -16.8 | Upgrade |
Free Cash Flow | 362.59 | 329.53 | 129.63 | 179.56 | 74.61 | -34.15 | Upgrade |
Free Cash Flow Growth | 123.36% | 154.21% | -27.81% | 140.67% | - | - | Upgrade |
Free Cash Flow Margin | 16.29% | 15.82% | 8.31% | 15.13% | 8.64% | -5.01% | Upgrade |
Free Cash Flow Per Share | 4.55 | 4.20 | 1.72 | 2.48 | 1.13 | -0.55 | Upgrade |
Cash Interest Paid | 3.95 | 3.45 | 3.51 | - | - | - | Upgrade |
Cash Income Tax Paid | 66.49 | 67.85 | 64.49 | 10.51 | 5.11 | 10.89 | Upgrade |
Levered Free Cash Flow | 483.6 | 392.34 | 101.12 | 151.79 | 81.27 | -37.03 | Upgrade |
Unlevered Free Cash Flow | 491.82 | 396.78 | 105.49 | 151.79 | 81.27 | -37.03 | Upgrade |
Change in Net Working Capital | -38.21 | 3.5 | 85.21 | -20.19 | 85.4 | 102.11 | Upgrade |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.